Most Recent
Judge grounds Moccona’s infringement claims over Vittoria’s coffee jar design
Vittoria has defeated claims in an intellectual property battle that it infringed on rival Koninklijke Douwe Egbert's trade mark for the design of its Moccona instant coffee jar.
$405M pelvic mesh settlement distribution can’t ‘drag on’, judge says
A judge has expressed concerns after hearing that up to 20,000 group members in three pelvic mesh class actions have yet to receive payment from $405 million in settlements approved in March last year.
Oracle can’t shut down court battle with ATO over software royalty taxes
A judge has refused to stay a fight between the tax office and software company Oracle over royalties, finding  determination of the dispute will guide 15 other cases.
Rugby Australia mulls cross-claim against Melbourne Rebels directors
Rugby Australia is considering an insolvent trading cross-claim against the directors of the Melbourne Rebels, in a suit by the failed team which was cut from next year’s Super Rugby Pacific competition.
Judge balks at $10M registration bill in stolen wages class action
The judge overseeing a $180.4 million settlement in a stolen wages class action has railed against Shine Lawyers' $10 million bill for the costs of registration, saying “something has gone seriously wrong”.
Sydney light rail class action pulls up to the High Court
The High Court has been asked to revive a class action over Sydney's light rail construction and weigh in on whether litigation funders can claim their commissions as damages.
New battle in Lexapro patent war between Lundbeck, Sandoz
Novartis unit Sandoz is appealing a tribunal decision in favour of pharmaceutical company Lundbeck over a licence to sell a generic version of leading antidepressant Lexapro.
Aristocrat sues rival, ex-employees over Dragon Link trade secrets
Aristocrat has sued competitor Light & Wonder and two former employees for allegedly using confidential information about its popular Dragon Link poker game to develop a competing product.
Lundbeck wins appeal in decade-long IP battle with Sandoz over Lexapro
Pharmaceuticals giant Lundbeck has succeeded in overturning IP Australia’s decision granting Novartis unit Sandoz a licence to sell a generic version of top-selling antidepressant Lexapro.
Sydney light rail class action thrown out on appeal
An appeals court has dismissed a class action on behalf of small businesses over alleged nuisance caused by the construction of Sydney’s $3 billion light rail network.